You are here

AstraZeneca

Tesaro Wants a Stronger Grip in Ovarian Cancer

Yahoo/Motley Fool

Tue, 03/27/18 - 10:10 pm

Clovis Oncology

AstraZeneca owes $192M in royalties from massive Merck deal, selumetinib licensor Array argues

Fierce Pharma

Wed, 03/21/18 - 09:19 am

Array Biopharma

AstraZeneca touts a fresh cut of Farxiga data targeting diabetes patients with chronic kidney disease

Endpoints

Tue, 03/20/18 - 09:38 am

chronic kidney disease

Why Amgen Shouldn't Use Its War Chest For A Celgene Megamerger

Investors Business Daily

Mon, 03/19/18 - 12:07 pm

Why A Biopharma Buying Spree May Target AstraZeneca, Bristol

Investors Business Daily

Sat, 03/17/18 - 09:57 am

Bristol-Myers Squibb

Vertex Pharmaceuticals

Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down

Fierce Pharma

Fri, 03/16/18 - 09:42 am

Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca — biotech’s shares plunge

Endpoints

Tue, 03/13/18 - 10:15 am

clinical trials

Top 5 boards for week ending March 10, 2018

CP Wire

Sun, 03/11/18 - 03:05 pm

AstraZeneca Goes Up Against 2 Cancer Upstarts

Motley Fool

Sat, 03/10/18 - 09:17 am

Clovis Oncology

PARP inhibitors

AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug

Fierce Biotech

Wed, 02/28/18 - 11:16 am

autoimmune disease

Needle-free flu vaccine will be back in clinics next flu season

Drug Delivery Business News

Fri, 02/23/18 - 10:11 am

needle free delivery

AstraZeneca's FluMist wins CDC committee's backing after two missed years

Fierce Pharma

Thu, 02/22/18 - 09:09 am

AstraZeneca hauls kidney disease drug into the clinic after handing Ionis $30M in cash, $300M in milestones

Endpoints

Tue, 02/20/18 - 11:07 am

Ionis Pharmaceuticals

AstraZeneca's (AZN) Imfinzi Gets FDA Nod for Label Expansion

Yahoo/Zacks.com

Mon, 02/19/18 - 11:42 am

non-small cell lung cancer

FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market

Endpoints

Sat, 02/17/18 - 10:44 am

AstraZeneca's Lynparza Now 'King' Of Its Class — Triumphing Over Tesaro

Investors Business Daily

Sat, 02/3/18 - 09:09 am

Clovis Oncology

AstraZeneca pins its hopes on China

Biopharma Dive

Fri, 02/2/18 - 10:54 pm

AstraZeneca sweeps out a PhIII asthma flop, a PD-1 drug and some other rejects as Q4 tally disappoints

Endpoints

Fri, 02/2/18 - 09:18 am

PD-1 inhibitors

AstraZeneca's 3-in-1 inhaler helps COPD patients in trial

Yahoo/Reuters

Fri, 01/26/18 - 09:37 am

clinical trials

Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma

Endpoints

Sat, 01/20/18 - 02:56 pm

Pages